EUGON XP 225IU INJECTION

Eugon XP 225IU Injection is a source of the active ingredient Menotrophin. This is an ovulation-stimulating agent and is part of a class of drugs known as gonadotropins. It is a highly pure mix of follicle-stimulating hormone (FSH) and the luteinizing hormone (LH). They are both natural hormones created in females and males. They aid the reproductive organs in working usually.
Eugon XP 225IU Injection can be utilized to manage infertility among women who have not been able to ovulate or have polycystic ovarian disorder and who haven’t been able to respond to treatment with a different medicine known as clomiphene. It also serves to assist multiple follicles and, consequently, increase fertility among women who are undergoing IVF (in-vitro fertilization) or other forms of assisted conception. It is also used for treating infertility in males due to a lower sperm count.
Do not use Eugon XP 225IU injection if you are allergic to menotrophin or any other ingredient of this medication. Don’t take this medication if you are suffering from an abnormal pituitary gland (a gland at the brain’s base that produces hormones, which include growth hormones) or in the hypothalamus (a part of the brain’s surface known as the thalamus, which regulates the body’s conditions like blood pressure and temperature) also in ovaries, the uterus the testicles, and breasts or in the prostate gland. Before you begin treatment, you’ll be examined for thyroid underactivity issues, hormone levels, and tumors in the hypothalamus and pituitary glands.
Do not take this medication if you suffer from ovarian cysts that aren’t caused by PCOD vaginal bleeding or menopausal symptoms, issues with your reproductive organs if your womb was removed, or if you are breastfeeding or pregnant. Tell your physician right away if you experience any of these symptoms like abdominal pain, swelling or diarrhea, weight gain, breathing difficulties, urination, or a decreased frequency of urine output. Inform your doctor if you’ve been diagnosed with liver problems or had a history of blood clotting disease before beginning treatment.